Quantbot Technologies LP Sells 9,201 Shares of National Health Investors, Inc. $NHI

Key Points

• Quantbot Technologies LP reduced its stake in National Health Investors, Inc. by 38.9% in the first quarter, leaving it with 14,458 shares valued at approximately $1,068,000.
• National Health Investors announced an increased quarterly dividend of $0.92 per share, up from $0.90, with a dividend yield of 4.7%.
• Analysts have issued favorable ratings on National Health Investors, with a consensus target price of $85.40, indicating positive sentiment on the stock's future performance.

Quantbot Technologies LP cut its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 38.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,458 shares of the real estate investment trust's stock after selling 9,201 shares during the period. Quantbot Technologies LP's holdings in National Health Investors were worth $1,068,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. GF Fund Management CO. LTD. purchased a new stake in shares of National Health Investors in the fourth quarter worth $58,000. Farther Finance Advisors LLC increased its stake in shares of National Health Investors by 5,000.0% in the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock worth $68,000 after purchasing an additional 900 shares in the last quarter. NewEdge Advisors LLC purchased a new stake in shares of National Health Investors in the fourth quarter worth $83,000. Jupiter Asset Management Ltd. purchased a new stake in shares of National Health Investors in the first quarter worth $206,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in shares of National Health Investors in the fourth quarter worth $226,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Price Performance

NHI stock traded up $0.68 during trading on Friday, hitting $78.33. 193,835 shares of the company's stock traded hands, compared to its average volume of 223,797. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $86.13. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. The business has a fifty day simple moving average of $72.74 and a 200 day simple moving average of $72.85. The stock has a market capitalization of $3.72 billion, a price-to-earnings ratio of 25.02, a P/E/G ratio of 3.34 and a beta of 0.73.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business had revenue of $70.27 million during the quarter, compared to analyst estimates of $86.46 million. During the same quarter last year, the business earned $1.18 earnings per share. National Health Investors's quarterly revenue was up 6.7% compared to the same quarter last year. As a group, research analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.7%. This is an increase from National Health Investors's previous quarterly dividend of $0.90. The ex-dividend date is Tuesday, September 30th. National Health Investors's dividend payout ratio (DPR) is 115.02%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on NHI. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective for the company in a research note on Thursday, July 10th. Truist Financial raised their target price on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Wells Fargo & Company raised their target price on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday. Finally, Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, National Health Investors has a consensus rating of "Buy" and an average target price of $84.20.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.